Welcome to New Zealand Clinical Research (NZCR). NZCR, formed in 2020 by the merger of Auckland Clinical Studies (ACS) and Christchurch Clinical Studies Trust (CCST) is New Zealand’s leading early phase clinical research provider.
Update 20th September 2021: Covid-19 community cases have been detected in New Zealand.The NZ Government has announced that Auckland will remain at COVID-19 Alert Level 3. The rest of NZ is at COVID-19 Alert Level 2. If you are a healthy participant in a current trial, please attend your visits as instructed by your Study Coordinator.
NZCR provides state of the art world class research units and the expertise to conduct complex early phase clinical research in healthy participant and patient populations over a wide range of therapeutic areas.
NZCR partners with global pharmaceutical and biotechnology companies to deliver excellence in clinical research.
The merger of the ACS and CCST research teams brings together over 35 years combined research excellence and a track record of completing over 500 trials involving over 15,000 participants.
Led by ACS and CCST’s founding Principal investigators, NZCR is the same great team ensuring timely delivery of research projects with participant safety and quality of data at the forefront.
New Zealand Clinical Research (NZCR) provides state of the art research facilities and the expertise to conduct complex early phase clinical research in healthy participant and patient populations.